Modern phenotypic drug discovery is a viable, neoclassic pharma strategy

  • J Med Chem. 2012 May 24;55(10):4527-38. doi: 10.1021/jm201649s.
Jonathan A Lee  1 ,  Mark T Uhlik ,  Christopher M Moxham ,  Dirk Tomandl ,  Daniel J Sall
Affiliations
  • 1. Department of Quantitative Biology, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA. [email protected]
PMID: 22409666 DOI: 10.1021/jm201649s